PATH | VRL
Menu

RSV Vaccine Use – The Missing Data

This article, published in Expert Review of Vaccines, explains the need for more data and knowledge on respiratory syncytial virus (RSV) epidemiology in different settings and age groups, as well as virus transmission and healthcare costs of the disease. The authors note that RSV is the single most important vaccine-preventable disease without a vaccine program, and that more data are needed to inform optimal approaches to disease control through vaccination.

Author: Drysdale SB, Sande CJ, Green CA, Pollard AJ

Published: 2016

» Visit web page (English)

(Located at www.tandfonline.com)

Citation: Drysdale SB, Sande CJ, Green CA, Pollard AJ. RSV Vaccine Use – The Missing Data. Expert Review of Vaccines. 2016;15(2):149-152.

Resource types: Peer-reviewed journal

Diseases/vaccines: Respiratory syncytial virus (RSV)

Topics: Immunization financing, Disease burden and surveillance, Disease/vaccine specific information

Regions: Global